Arkolith/Insider Trading/TEVA/Form 4

Shields Matthew

EVP, Global OperationsTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed Jun 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$532K
Net Open-Market Flow
-$532K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2026Option exercise(M)16K——26K
Jun 3, 2026Sell(S)16K$32.87$532K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 3, 2026Option exercise(M)16K—$032K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-257344) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML